-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
▎ WuXi AppTec content team editor
On August 9, 2022, Cure Rare Disease (CRD), a Boston-based nonprofit organization, announced that the FDA had approved its IND application for a CRISPR gene-edited therapy called CRD-TMH-001 for the treatment of Duchenne muscular dystrophy (DMD
Richard Hogan (Image source: Cure Rare Disease official website)
In 2019, he teamed up with the University of Massachusetts School of Medicine, Yale University, and other institutions to build a team
Terry's condition was also caused
Image credit: 123RF
To reduce the body's response to the virus, Terry also needs to take immunosuppressants
As WuXi AppTec's CTDMO focused on cell and gene therapies, WuXi Biotech is committed to accelerating and transforming the development, testing, production and commercialization of gene and cell therapies and other high-end therapies